Enabling Novel Pharmaceutical Therapies through 3D-Printing

Aprecia continues its leadership position in the pharmaceutical application of 3D-Printing. Aprecia will be launching its two new platforms later this year that will provide additional benefits in early development FIH clinical as well as small and large scale commercial production. In this presentation, Aprecia will discuss the flexibility and precision these platform provide in delivering novel products to the market.

Continue reading “Enabling Novel Pharmaceutical Therapies through 3D-Printing”